Early dynamic risk stratification with baseline troponin levels and 90-minute ST-segment resolution to predict 30-day cardiovascular mortality in ST-segment elevation …

MW Sherwood, DA Morrow, BM Scirica, S Jiang… - American heart …, 2010 - Elsevier
BACKGROUND: Troponin is the preferred biomarker for risk stratification in non-ST
elevation ACS. The incremental prognostic use of the initial magnitude of troponin elevation …

Performance of the Thrombolysis in Myocardial Infarction (TIMI) ST-elevation myocardial infarction risk score in a national cohort of elderly patients

SS Rathore, KP Weinfurt, JAM Foody… - American heart journal, 2005 - Elsevier
BACKGROUND: The TIMI ST-elevation myocardial infarction (STEMI) score was developed
and validated in a randomized controlled trial population. We sought to assess its accuracy …

Impact of age on short-and long-term mortality of patients with ST-elevation myocardial infarction in the VIENNA STEMI network

PM Haller, B Jäger, S Farhan, G Christ… - Wiener klinische …, 2018 - Springer
Background and aim Our senescent society includes a growing number of elderly people
suffering from ST-elevation myocardial infarction (STEMI); however, exactly this population …

Ten-year mortality in patients with ST-elevation myocardial infarction

N Watanabe, K Takagi, A Tanaka, N Yoshioka… - The American Journal of …, 2021 - Elsevier
Knowledge of the long-term prognosis (> 10 years) and mortality predictors of ST-elevation
myocardial infarction (STEMI) patients who have undergone primary percutaneous coronary …

Correlation between markers of reperfusion and mortality in ST-elevation myocardial infarction: a systematic review.

S Sattur, B Sarwar, TJ Sacchi… - The Journal of invasive …, 2014 - europepmc.org
Objective To correlate early and late mortality with markers of reperfusion in ST-elevation
myocardial infarction (STEMI). Background Early reperfusion improves STEMI outcomes …

THEROLEOFBIOCHEMICALMARKERSAND PATIENT-REPORTED OUTCOMES IN PREDICTINGCOMPOSITEONE-YEARENDPOINTINST …

IR Vyshnevska, OV Petyunina, MP Kopytsya… - Polski Merkuriusz …, 2023 - polmerklek.pl
Aimofourstudywastodeterminetheroleofthec… patientswithSTEMIwhohaveundergoneprim…
. Materials and methods: The study included 165 patients admitted with STEMI within 12 …

Early Discharge After Primary Percutaneous Coronary Intervention: The Added Value of N‐Terminal Pro–Brain Natriuretic Peptide to the Z wolle Risk Score

DAAM Schellings, A Adiyaman… - Journal of the …, 2014 - Am Heart Assoc
Background The Zwolle Risk Score (ZRS) identifies ST‐elevation myocardial infarction
(STEMI) patients treated with primary percutaneous coronary intervention (PPCI) eligible for …

The universal classification is an independent predictor of long-term outcomes in acute myocardial infarction

MA Gonzalez, DJ Eilen, RA Marzouq… - Cardiovascular …, 2011 - Elsevier
BACKGROUND: The long-term outcomes of patients with acute myocardial infarction (AMI)
according to the universal classification (UC) are unknown. We investigated whether the …

A practical risk score to predict 24-month post-discharge mortality risk in patients with non-ST-segment elevation myocardial infarction

R Fu, C Song, J Yang, C Gao, Y Wang, H Xu… - Circulation …, 2020 - jstage.jst.go.jp
Background: Risk stratification of patients with non-ST-segment elevation myocardial
infarction (NSTEMI) is important in terms of treatment strategy selection. Current efforts have …

Short-and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkers

CM Westerhout, Y Fu, MS Lauer, S James… - Journal of the American …, 2006 - jacc.org
Objectives: The purpose of this study was to develop 30-day and 1-year risk stratification
models for non–ST-segment elevation acute coronary syndrome (NSTE-ACS) patients that …